Terms: = Endocrine gland cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
468 results:
1. [Testicular involvement in pediatric lymphoid tumors: a review of the literature and a series of clinical observation].
Korneeva M S; Batmanova N A; Panferova T R; Valiev T T
Urologiia; 2024 Mar; (1):107-112. PubMed ID: 38650415
[TBL] [Abstract] [Full Text] [Related]
2. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer.
Bereska JI; Janssen BV; Nio CY; Kop MPM; Kazemier G; Busch OR; Struik F; Marquering HA; Stoker J; Besselink MG; Verpalen IM;
Eur Radiol Exp; 2024 Feb; 8(1):18. PubMed ID: 38342782
[TBL] [Abstract] [Full Text] [Related]
3. A Clinical Prediction Model to Assess Risk for Pancreatic cancer Among Patients With Acute Pancreatitis.
Wang L; Rahimi Larki N; Dobkin J; Salgado S; Ahmad N; Kaplan DE; Yang W; Yang YX
Pancreas; 2024 Mar; 53(3):e254-e259. PubMed ID: 38266222
[TBL] [Abstract] [Full Text] [Related]
4. An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in patients with papillary thyroid cancer.
Gao Y; Wang W; Yang Y; Xu Z; Lin Y; Lang T; Lei S; Xiao Y; Yang W; Huang W; Li Y
BMC Cancer; 2024 Jan; 24(1):69. PubMed ID: 38216936
[TBL] [Abstract] [Full Text] [Related]
5. Early Ovarian cancer Detection in the Age of Fallopian Tube Precursors: A Systematic Review.
Greenwood A; Woodruff ER; Nguyen C; Piper C; Clauset A; Brubaker LW; Behbakht K; Bitler BG
Obstet Gynecol; 2024 Mar; 143(3):e63-e77. PubMed ID: 38176019
[TBL] [Abstract] [Full Text] [Related]
6. Mendelian randomization suggests a causal relationship between gut dysbiosis and thyroid cancer.
Zhu F; Zhang P; Liu Y; Bao C; Qian D; Ma C; Li H; Yu T
Front Cell Infect Microbiol; 2023; 13():1298443. PubMed ID: 38106470
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Diagnostics and [
de Koster EJ; Morreau H; Bleumink GS; van Engen-van Grunsven ACH; de Geus-Oei LF; Links TP; Wakelkamp IMMJ; Oyen WJG; Vriens D
Thyroid; 2024 Jan; 34(1):41-53. PubMed ID: 38009209
[No Abstract] [Full Text] [Related]
8. Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study.
Savoye I; Silversmit G; Bourgeois J; De Gendt C; Leroy R; Peacock HM; Stordeur S; de Sutter P; Goffin F; Luyckx M; Orye G; Van Dam P; Van Gorp T; Verleye L
Eur J Cancer; 2023 Dec; 195():113402. PubMed ID: 37922631
[TBL] [Abstract] [Full Text] [Related]
9. Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus.
Sokolenko AP; Bakaeva EK; Venina AR; Kuligina ES; Romanko AA; Aleksakhina SN; Belysheva YV; Belogubova EV; Stepanov IA; Zaitseva OA; Yatsuk OS; Togo AV; Khamgokov ZM; Kadyrova AO; Pirmagomedov AS; Bolieva MB; Epkhiev AA; Tsutsaev AK; Chakhieva MD; Khabrieva KM; Khabriev IM; Murachuev MA; Buttaeva BN; Baboshkina LS; Bayramkulova FI; Katchiev IR; Alieva LK; Raskin GA; Orlov SV; Khachmamuk ZK; Levonyan KR; Gichko DM; Kirtbaya DV; Degtyariov AM; Sultanova LV; Musayeva HS; Belyaev AM; Imyanitov EN
Breast Cancer Res Treat; 2024 Jan; 203(2):307-315. PubMed ID: 37851290
[TBL] [Abstract] [Full Text] [Related]
10. Treatment of Recurrent Low-grade Serous Ovarian cancer With MEK Inhibitors: A Systematic Review.
Kulkarni A; Cooke C; Fazelzad R; Fung-Kee-Fung M; May T; Zigras T
Am J Clin Oncol; 2024 Jan; 47(1):11-16. PubMed ID: 37823720
[TBL] [Abstract] [Full Text] [Related]
11. Bevacizumab Treatment for Low-Grade Serous Ovarian cancer: A Systematic Review.
Lazurko C; Linder R; Pulman K; Lennox G; Feigenberg T; Fazelzad R; May T; Zigras T
Curr Oncol; 2023 Sep; 30(9):8159-8171. PubMed ID: 37754507
[TBL] [Abstract] [Full Text] [Related]
12. ThyroidPrint®: clinical utility for indeterminate thyroid cytology.
Olmos R; Domínguez JM; Vargas-Salas S; Mosso L; Fardella CE; González G; Baudrand R; Guarda F; Valenzuela F; Arteaga E; Forenzano P; Nilo F; Lustig N; Martínez A; López JM; Cruz F; Loyola S; Leon A; Droppelmann N; Montero P; Domínguez F; Camus M; Solar A; Zoroquiain P; Roa JC; Muñoz E; Bruce E; Gajardo R; Miranda G; Riquelme F; Mena N; González HE
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37671897
[TBL] [Abstract] [Full Text] [Related]
13. Diagnosis of thyroid disease using deep convolutional neural network models applied to thyroid scintigraphy images: a multicenter study.
Zhao H; Zheng C; Zhang H; Rao M; Li Y; Fang D; Huang J; Zhang W; Yuan G
Front Endocrinol (Lausanne); 2023; 14():1224191. PubMed ID: 37635985
[TBL] [Abstract] [Full Text] [Related]
14. Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis.
Yang J; Han Y; Min Y; Chen C; Chen J; Xiang K; Liao J; Feng Y; Hu D; Yin G
Front Endocrinol (Lausanne); 2023; 14():1176512. PubMed ID: 37576962
[TBL] [Abstract] [Full Text] [Related]
15. pH-Sensitive Biomimetic Nanosystem Based on Large-Pore Mesoporous Silica Nanoparticles with High Hyaluronidase Loading for Tumor Deep Penetration.
Song X; Li CL; Qiu N; Lv QY; Wu X; Cui HF
ACS Appl Mater Interfaces; 2023 Aug; 15(32):38294-38308. PubMed ID: 37542453
[TBL] [Abstract] [Full Text] [Related]
16. Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine-needle aspiration.
Jin X; Lew M; Pantanowitz L; Iyengar JJ; Haymart MR; Papaleontiou M; Broome D; Sandouk Z; Raja SS; Hughes DT; Smola B; Jing X
Diagn Cytopathol; 2023 Nov; 51(11):698-704. PubMed ID: 37519144
[TBL] [Abstract] [Full Text] [Related]
17. Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer.
Yun HJ; Lee JS; Lee JS; Kim SM; Chang H; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2023; 14():1166640. PubMed ID: 37424860
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients.
Mangieri CW; Valenzuela CD; Solsky IB; Erali RA; Pardee T; Lima CMSR; Howerton R; Clark CJ; Shen P
J Surg Oncol; 2023 Oct; 128(5):844-850. PubMed ID: 37341164
[TBL] [Abstract] [Full Text] [Related]
19. Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.
Liu TT; Yin DT; Wang N; Li N; Dong G; Peng MF
Front Endocrinol (Lausanne); 2023; 14():1140094. PubMed ID: 37324256
[TBL] [Abstract] [Full Text] [Related]
20. RAS and Other Molecular Targets in Pancreatic cancer: The Next Wave Is Coming.
Miller-Phillips L; Collisson EA
Curr Treat Options Oncol; 2023 Aug; 24(8):1088-1101. PubMed ID: 37296367
[TBL] [Abstract] [Full Text] [Related]
[Next]
